BioSpace News Archive

Extendicare Inc. reported results for the three and twelve months ended December 31, 2020.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today indicated that the clinical program for Berubicin is on track to start enrolling patients in March 2021

Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, announced today the publication of new data in the journal CELLS.

Synaptogenix, Inc., an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, announced that it will attend two upcoming scientific industry conferences.

Following the acquisition of Sairiyo Therapeutics and its biotech R&D core competencies, PharmaDrug has undertaken efforts to expand its research activities in the pharmaceutical psychedelics space.

The growing popularity of customized medicine is reshaping the global compounding pharmacies market outlook.

By 2026, the North America cell line development market size is estimated to be around $2.7 billion, triggered by the escalating demand for COVID-19 treatments that involve monoclonal antibodies.

Break Through Cancer (www.breakthroughcancer.org) today announced its formal launch as a public foundation designed to find new solutions to the most intractable challenges in cancer.

Yesterday, Novo Nordisk a global healthcare company with Canadian headquarters in Mississauga, and the University of Toronto announced a new research hub at U of T’s Mississauga campus that will bring leading public health experts together to help reduce chronic illnesses across the globe.

Benchling for Education expands academic market leadership to help teachers working remotely engage the next generation of biotech innovators